"Advancing the understanding of Alzheimer’s disease and related dementias through comprehensive patient evaluations and cutting edge research."

During the past decade, University of California, Davis; Alzheimers Disease Center, Department of Neurology conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of California, Davis; Alzheimers Disease Center, Department of Neurology" #1 collaborator was "National Institute on Aging (NIA)" with 2 trials as a collaborator, "East Oakland Sports Center" with 1 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Tice Creek Fitness Center" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "University of California, Davis; Alzheimers Disease Center, Department of Neurology" are "Alzheimer's Disease" (4 trials), "Alzheimer Disease" (2 trials), "Cognitive Decline" (1 trials), "Cognitive Impairment" (1 trials) and "Dementia" (1 trials). Many other conditions were trialed in "University of California, Davis; Alzheimers Disease Center, Department of Neurology" in a lesser frequency.

Most popular intervention types in "University of California, Davis; Alzheimers Disease Center, Department of Neurology" are "Drug" (6 trials), "Behavioral" (2 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Crenezumab" (3 trials), "Placebo" (3 trials), "Aerobic Exercise" (1 trials), "Bapineuzumab 0.5 mg/kg" (1 trials) and "Bapineuzumab 1.0 m/kg" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of California, Davis; Alzheimers Disease Center, Department of Neurology" are 9 trials for "All" genders.

Currently, there are NaN active trials in "University of California, Davis; Alzheimers Disease Center, Department of Neurology". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University of California, Davis; Alzheimers Disease Center, Department of Neurology, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of California, Davis; Alzheimers Disease Center, Department of Neurology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".